RAUL SUSTAITA: Open Payments
NPI 1801894704 · DONNA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 21 payments from 9 companies in 2025. Trend: 2023 $512 · 2024 $652 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $81 |
| Novo Nordisk Inc | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $53 |
| Abbott Laboratories | 2 | $47 |
| Amgen Inc. | 1 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Dexcom G6 Transmitter, Kerendia, FREESTYLE LIBRE 3, REPATHA, Rybelsus, MOUNJARO, GEMTESA, Ozempic.
Industry payments across TX — which companies pay providers there.
